BIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture - - PowerPoint PPT Presentation

biost stat 578 a statistical methods in infectious
SMART_READER_LITE
LIVE PREVIEW

BIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture - - PowerPoint PPT Presentation

BIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture 16 February 26, 2009 Cholera: ecological determinants and vaccination Latest big epidemic in Zimbabwe Support International Vaccine Institute National Institute of


slide-1
SLIDE 1

BIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture 16 February 26, 2009 Cholera: ecological determinants and vaccination

slide-2
SLIDE 2
slide-3
SLIDE 3

Latest big epidemic in Zimbabwe

slide-4
SLIDE 4

Support

  • International Vaccine Institute
  • National Institute of Allergy and Infectious

Diseases ’Epidemiology and Ecology of Vibrio cholerae in Bangladesh’ grant 5R01AI039129-08

  • National Institute of General Medical

Sciences MIDAS grant 5U01GM070749-02

– “Containing Bioterrorist and Emerging Infectious Diseases”

slide-5
SLIDE 5

Ecological & Epidemiological Publications

  • Longini, I.M., Yunus, M., Zaman, K., Siddique, A.K., Sack, R.B. and

Nizam, A.: Epidemic and endemic cholera trends over thirty-three years in Bangladesh. Journal of Infectious Diseases 186, 246-251 (2002).

  • Sack, R.B., Siddique, K., Longini, I.M., et al.: A four year study of the

epidemiology of Vibrio cholerae in four rural areas in Bangladesh. Journal

  • f Infectious Diseases 187, 96-101 (2003).
  • Huq, A., Sack, R.B., Nizam, A., Longini, I.M., et al.: Critical factors

influencing the occurrence of Vibrio cholerae in the environment of

  • Bangladesh. Applied and Environmental Microbiology 17, 4645-4654

(2005).

  • Longini, I.M., Nizam, A., Ali, M., Yunus, M., Shenvi, N. and Clemens,

J.D.: Controlling endemic cholera with oral vaccines. Public Library of Science (PloS), Medicine 4 (11) 2007: e336 doi:10.1371/journal.pmed.0040336

slide-6
SLIDE 6

Ecology of Cholera

slide-7
SLIDE 7

Cholera Vibrios

slide-8
SLIDE 8

Copepods

slide-9
SLIDE 9

Humans

slide-10
SLIDE 10

Ecology of Cholera in Rural Bangladesh

slide-11
SLIDE 11

Support

  • National Institute of Allergy and Infectious

Diseases grant R01AI039129

– “Epidemiology and Ecology of Vibrio cholerae in Bangladesh”

  • National Institute of General Medical Sciences

MIDAS grant 5U01GM070749

– “Containing Bioterrorist and Emerging Infectious Diseases”

  • International Vaccine Institute, Seoul Korea
slide-12
SLIDE 12

Ecology of Cholera in Rural Bangladesh

  • 1997 – 2001: Four sites
  • 2004 – 2008: Two sites
slide-13
SLIDE 13

Surveillance Sites In Bangladesh

Mathbaria

Sunderbans Sunderbans

slide-14
SLIDE 14

Surveillance Sites In Bangladesh

Mathbaria

Sunderbans Sunderbans

slide-15
SLIDE 15

Rainfall /Water Volume / Water Depth Concentration Of Organic Matter Sunshine Phyto- plankton CO2 pH

  • V. cholerae in

Environment Salinity Nutrients Cholera in Humans Temperature/ Season Dissolved O2

  • +

+ + + + + + + + + + +

  • +

?

Zoo- plankton + + + +

Hypothesized Associations

+

slide-16
SLIDE 16

2 0 0 4 0 0 6 0 0 8 0 0 1 0 0 0 1 2 0 0

C E C E C E C E C E C E C E C E C E C E C E C E B C E B C E B C E B C E B C E B

I n a b a O g a w a B e n g a l

1 9 6 6 1 9 6 9 1 9 7 2 1 9 7 5 1 9 7 8 1 9 8 1 1 9 8 2 1 9 8 5 1 9 8 8 1 9 9 1 1 9 9 4 1 9 9 7

Cases Cases

2 0 0 4 0 0 6 0 0 8 0 0 1 0 0 0 1 2 0 0

C E C E C E C E C E C E C E C E C E C E C E C E C E C E C E C E

I n a b a O g a w a

C l a s s i c a l V . c h o l e r a e O 1 E l T o r V . c h o l e r a e O 1 C l a s s i c a l a n d E l T o r V . c h o l e r a e O 1 E l T o r V . c h o l e r a e O 1 a n d V . c h o l e r a e O 1 3 9 E l T o r V . c h o l e r a e O 1

Source: Longini, I.M., et al., J Infect Dis 186, 246-251 (2002).

slide-17
SLIDE 17

Average monthly number cholera cases over the 33 year period 1966-1998, Matlab, Bangladesh.

10 20 30 40 50 60 70 80 90 100 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Month Average Number of Cases

Source: Longini, I.M., et al., J Infect Dis 186, 246-251 (2002).

slide-18
SLIDE 18
  • 0.2
  • 0.1

0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1 5 10 15

Total

Lag (months) Autocorrelation

95% Confidence Limits

Correlogram for total cholera cases over the 33 year period 1966-1998, Matlab, Bangladesh

Source: Longini, I.M., et al., J Infect Dis 186, 246-251 (2002).

slide-19
SLIDE 19

Correlogram for Inaba and Ogawa serotypes over the 33 year period 1966-1998, Matlab, Bangladesh

  • 0.2
  • 0.1

0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1 5 10 15

Inaba

Lag (months) Autocorrelation

95% Confidence Limits

  • 0.2
  • 0.1

0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1 5 10 15

Ogawa

Lag (months) Autocorrelation

95% Confidence Limits

Source: Longini, I.M., et al., J Infect Dis 186, 246-251 (2002).

slide-20
SLIDE 20

El Tor cholera with Classical Toxin

Dehydration status of V. cholerae O1 biotype El Tor infected patients in Bakerganj:

1998 - 2001 and 2004 - 06

33.3 46.9 40 30.8 53.3 67.9 78.8

10 20 30 40 50 60 70 80 90 1998 (n=33) 1999 (n=32) 2000 (n=15) 2001 (n=13) 2004 (n=30) 2005 (n=28) 2006 (n=52)

Years Percentage

None Some Severe

slide-21
SLIDE 21

8th Cholera Pandemic

  • El Tor vibrio with Classical toxin
slide-22
SLIDE 22

1997 – 2001

slide-23
SLIDE 23

2004 – 2008

slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26
slide-27
SLIDE 27
slide-28
SLIDE 28
slide-29
SLIDE 29
slide-30
SLIDE 30
  • Simultaneous clinical and environmental

surveillance every 15 days, at four sites:

  • began in March, 1997 at Matlab and

Chhatak

  • began in June, 1997 at Bakerganj and

Chaugaucha

Study Design

slide-31
SLIDE 31

Methods: Clinical Surveillance

  • Each site visited for three days by two

physicians

  • All patients seen with watery diarrhea

admitted into study

  • Stool culture for V. cholerae
slide-32
SLIDE 32

Four surface waters (ponds, lakes, rivers) sampled at each clinical site

  • V. cholerae identification

Culture DNA probes to identify cholera toxin-producing

  • rganisms
  • Zooplankton and phytoplankton, identification &

enumeration

  • Environmental parameters (physical, coliforms)

Environmental Surveillance

slide-33
SLIDE 33

Methods: Statistical Analyses

Goal: Build a regression model to

  • identify environmental variables that are

associated with occurrence of cholera cases in humans, quantify associated risk

  • identify time lag between changes in

environmental variables and associated changes in # of cholera cases Quantifying Associations Between Environmental Variables and Cholera Outbreaks

slide-34
SLIDE 34

Methods: Statistical Analyses

  • Initial screening: lagged correlations between

# of cholera cases & environmental variables

  • Further screening: Stepwise regression of # of

cases on lagged environmental variables

  • Poisson regression of # of cholera cases on

selected environmental variables; risk ratios quantifying change in risk of cholera associated with changes in environment. Quantifying Associations Between Environmental Variables and Cholera Outbreaks

slide-35
SLIDE 35

1 0 2 0 3 0 4 0 5 0

M a r '9 7 J u n S e p D e c M a r '9 8 J u n S e p D e c M a r '9 9 J u n S e p D e c M a r '0 0 J u n S e p D e c

O 1 3 9 (n = 5 6 ) O 1 (n = 7 9 ) D ia r r h e a

1 0 2 0 3 0 4 0 5 0 O 1 3 9 ( n = 1 0 8 ) O 1 ( n = 2 9 6 ) D i a r r h e a

Matlab Bakergonj

Cholera and Diarrhea Cases Over Time

# Cases # Cases

slide-36
SLIDE 36

# Cases

1 0 2 0 3 0 4 0 5 0

M a r '9 7 J un S e p D e c M a r '9 8 J un S e p D e c M a r '9 9 J un S e p D e c M a r '0 0 J un S e p D e c

O 1 3 9 (n = 8 ) O 1 (n = 2 9 ) D ia r r h e a

1 0 2 0 3 0 4 0 5 0 O 1 3 9 ( n = 6 ) O 1 ( n = 8 5 ) D i a r r h e a

Chhatak Chaugacha # Cases

Cholera and Diarrhea Cases Over Time

slide-37
SLIDE 37

Results: Environmental Surveillance

Variable n mean1 max1 % + Copepod Count 1022 1.7 4.4 54

  • Cyanobact. Ct. 1042 4.3 8.1 72

Probe Count 1013 1.0 4.5 26 Fecal Colif. Ct. 991 1.4 4.5 96 _______________________________________

  • 1. Log scale
slide-38
SLIDE 38

Results: Environmental Surveillance

Variable n mean (std) min. max. Conductivity(μS) 1038 243 (220) 15 1568 Water Temp (OC ) 1038 28 (4) 16 38 Water Depth (ft) 1035 8 (6) 1 60 Air Temp. (OC ) 1038 28 (5) 15 39 pH 1029 7 (1) 5 9 Diss.O2(mg/l) 658 4 (4) 0 53 Salinity(ppt) 1008 .1 (.1) 0 1

slide-39
SLIDE 39

5 10 15 20 25 30

Mar '97 Jun Sep Dec Mar '98 Jun Sep Dec Feb '99 May Aug Nov

  • Chol. Cases .

50 100 150 200 250 300 350 400

Conductivity (uS) .

O139 O1 Conductivity

Lag Correlation Lag Correlation No lag 0.54 6 Weeks 0.43 2 Weeks 0.58 8 Weeks 0.15 4 Weeks 0.47

Cholera Cases and Lake Water Conductivity Over time in Bakerganj

slide-40
SLIDE 40

5 10 15 20 25 30

Mar '97 Jun Sep Dec Mar '98 Jun Sep Dec Mar '99 Jun Sep Dec

  • Chol. Cases

2 4 6 8 10 12 Water Depth (ft) O139 O1 Water Depth

Lag Correlation Lag Correlation No lag

  • 0.28

6 Weeks

  • 0.43

2 Weeks

  • 0.49

8 Weeks

  • 0.38

4 Weeks

  • 0.43

Cholera Cases and Pond Water Depth Over time in Bakerganj

slide-41
SLIDE 41

5 10 15 20 25 30

M ar '97 Jun S ep Dec M ar '98 Jun S ep Dec M ar '99 Jun S ep Dec

  • Chol. Cases .

0 .5 1 1 .5 2 2 .5

Probe Count . (log10)

O 1 3 9 O 1 C o nduc tiv ity

Lag Correlation Lag Correlation No lag 0.02 6 Weeks 0.07 2 Weeks 0.15 8 Weeks 0.27 4 Weeks 0.10

Cholera Cases and Lake Water Probe Results Over time in Matlab

slide-42
SLIDE 42

Lagged Poisson Regression

, ... ) | ln(

2 1

2 2 1 1

kij ij ij

kijt kij ijt ij ijt ij ij ijt it

X X X X

τ τ τ

β β β β μ

− − −

+ + + + =

t ≥ max{τ1ij , τ2ij ,…, τkij}. Let Yit be the number of reported cholera cases at time t, in area i. We assume that Yit follows a Poisson distribution with mean μit. Xijt is the jth predictor at time t, in area i.

slide-43
SLIDE 43

Regression results

  • RRij(☺) = exp()

– goes with a lagged Xij – change in Xij

  • Predictions and credibility intervals

constructed using MCMC methods for Poisson regression

slide-44
SLIDE 44

Results: Poisson Regression

Bakergonj River Predictors

Risk Ratio for Variable (lag1) Δ change of Δ (95% CI)

  • Conduct. (8) +150μS 1.3 (1.2, 1.3)

Copepods (0) +10 1.4 (1.2, 1.7) ______________________________________

  • 1. Lag, in weeks, between a change of of Δ units in the

environmental variable and a subsequent change in the number of cholera cases.

slide-45
SLIDE 45

Poisson Regression Results:

Bakergonj Lake 2 Predictors

Risk Ratio for Variable (lag) Δ change of Δ (95% CI)

  • Conduct. (4) +150μS 4.1 (2.6, 6.6)

PH (8) +1 1.7 (1.3, 2.2)

  • Cyanobact. (2) +10 1.9 (1.6, 2.3)
slide-46
SLIDE 46

Poisson Regression Results:

Bakergonj Pond Predictors

Risk Ratio for Variable (lag) Δ change of Δ (95% CI) Water Depth (2) -2 ft. 2.5 (1.9, 3.3) Copepods (2) +10 2.2 (1.7, 3.0)

slide-47
SLIDE 47

Bakergonj Pond Predictors Water Depth (2) and Copepods (2)

5 10 15 20 25 30

Mar '97 May Jul Sep Nov Jan '98 Mar May Jul Sep Nov Jan '99 Mar May Jul Sep Nov

O bs. C ases. 5 10 15 20 25 30

  • Pred. C ases.

O139 O1 Predicted 95% Upper CI

slide-48
SLIDE 48

5 10 15 20 25

Jun '97 Aug Oct Dec Feb '98 Apr Jun Aug Oct Dec Feb '99 Apr Jun Aug Oct Dec Feb '00 Apr Jun Aug Oct Dec

# Cholera Cases Observed Predicted 95% Upper Pred. Limit

One month prediction in Bakerganj lake using water temperature, ctx gene probe count, conductivity, and rainfall

slide-49
SLIDE 49
slide-50
SLIDE 50
slide-51
SLIDE 51

Summary: I

  • Both V. cholerae O1 and O139 are

widespread in Bangladesh

  • Seasonal patterns of cholera are observed, but

are not always identical in different locations

  • Cholera outbreaks in different geographic

areas may be synchronous

  • Not all diarrhea outbreaks are cholera
slide-52
SLIDE 52

Summary: II

  • The main environmental predictors of cholera
  • utbreaks were:

Conductivity Water depth Concentrations of copepods

slide-53
SLIDE 53

Controlling Endemic Cholera With Killed Oral Vaccines

slide-54
SLIDE 54

RATIONALE

  • Advances in dehydration therapy make

case fatality rate low

  • Still, estimated 150,000 deaths per year in

most impoverished countries

  • Licensed, oral killed whole-cell cholera

vaccines (OCV) have been available for

  • ver a decade

– 70% efficacy against disease – 2 years protection

slide-55
SLIDE 55

“The role of OCVs as an additional public health tool to improve cholera control activities seems to be a promising strategy that needs to be further defined, especially for endemic settings.”4

4. Weekly Epidemiological Record, 5 August, 2005. World Health Organization.

slide-56
SLIDE 56

Introduction

  • Studies have shown that
  • rally administered killed

cholera vaccines are safe and protective

  • Vaccines have not been

adopted for use in most endemic regions due to cost and efficacy concerns

slide-57
SLIDE 57

Recent Analysis

  • Mid 1980’s randomized vaccine trial with OCV in

Matlab, Bangladesh

– 183,826 subjects – Current GIS mapping – Ali, M et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366, 44 - 49 (2005). – Durham, L.K., Longini, I.M., Halloran, et al.: Estimation of vaccine efficacy in the presence of waning: Application to cholera vaccines. American Journal of Epidemiology 147, 948- 959 (1998).

slide-58
SLIDE 58

Source: Durham, L.K., Longini, I.M., Halloran, M.E., Clemens, J.D., Nizam, A. and Rao, M.: Am J Epidem 147, 948-959 (1998).

slide-59
SLIDE 59

Source: Durham, L.K., Longini, I.M., Halloran, M.E., Clemens, J.D., Nizam, A. and Rao, M.: Am J Epidem 147, 948-959 (1998).

slide-60
SLIDE 60

Endemic Cholera

  • Cholera always present
  • Triggering events cause outbreaks

– Sack RB et al. . A 4-Year Study of the Epidemiology of Vibrio cholerae in Four Rural Areas of Bangladesh. J Infect Dis, (2003). – Huq et al. Critical factors influencing the

  • ccurrence of Vibrio cholerae in the

environment of Bangladesh. Applied and Environmental Biology (2005).

slide-61
SLIDE 61

Goals of Simulation Model

  • Calibrate to historical attack rate and vaccine

effectiveness data

  • Simulate use of cholera vaccine at various

coverage levels, study effectiveness measures

  • Longini, I.M., Nizam, A., Ali, M., Yunus, M.,

Shenvi, N., Clemens, J.D.: Controlling endemic cholera with oral vaccines. (In preparation)

slide-62
SLIDE 62

Simulator Overview

Input Population Code Outputs

  • Population of

Matlab in 1985

  • ANSI c code

models cholera natural history and community level transmission

  • Developed on
  • unix. Portable
  • 1000 runs per

simulation

  • Illness attack

rates

  • Effectiveness

measures

  • Spatial distribution
  • f cholera cases
slide-63
SLIDE 63

Simulator Elements

  • Disease natural history model and parameters
  • Community-level transmission of cholera

infection

  • Matlab population demographics (age, gender,

location, travel within Matlab)

  • Historical illness attack rate data for model

calibration

slide-64
SLIDE 64

Cholera Natural History

Susceptible Latent Ill Asymptomatic Recovered/ Removed

In each subpopulation, on any given day of the epidemic, there is a probability of infection, determined by an infection function (next slide)

90% 10%

1 day: 40% 2 days: 40% 3-5 days: 20%

Uniform distribution 7-14 days In each subpopulation, on any given day of the epidemic, there is a probability of infection, determined by an infection function (next slide)

Additional assumptions:

  • Ill shed at 10 times the rate
  • f asymptomatics
  • Working males:
  • circulate >= 1 day
  • Pr(withdrawal after ill)= 0.75

Uniform distribution 7-14 days

1 day: 40% 2 days: 40% 3-5 days: 20%

slide-65
SLIDE 65

Infection Function

The probability that a susceptible person will be infected in a particular location on day t is: Where p = transmission probability Ө = 1 – vaccine efficacy against susceptibility (VES) x = 1 if susceptible is vaccinated, 0 if unvaccinated b = seasonal boost factor for first month nuv(t) = # unvacc. infectious people nv(t) = # vacc. infectious people Ф = 1 – vaccine efficacy against infectiousness (VEI)

( ) ( )

1 (1 ) (1 )

uv v

n t n t x x

f bp bp θ θ φ = − − − ⎡ ⎤ ⎣ ⎦

slide-66
SLIDE 66

Model Calibration

Model input parameters p: 0.000009 b: 10 VES: 0.7 VEI: 0.5 Number of initial infectives: 5 Probability of withdrawal given ill: 0.75 Probability asymptomatic: 0.9

slide-67
SLIDE 67

Population Characteristics

  • 183,826 subjects from Matlab
  • 50.5% Female 49.5% Males
  • Geographic map

– Bari code – X,Y coordinates – Age on 1/1/1985

  • Vaccinated where children 2 – 15 years
  • ld and women > 15 years old.
slide-68
SLIDE 68

Population Characteristics

Matlab “Grid”

  • Matlab area mapped to 64 ‘sub-regions’
  • Each subject mapped to one of the sub-

regions based on the GIS location

Matlab

slide-69
SLIDE 69

Population Characteristics

Distribution of Population Across the Grid

slide-70
SLIDE 70

Population Characteristics

Connectivity Between Sub-regions

  • Males over 16 years old, and 50% of males

between 14 -16 years old were randomly assigned a work sub-region according to the following distance function: –55% work and reside in same sub-region –35% work 4-10km away from residence sub-region –10% work >10km away4

  • 4. Distance function derived from time traveled to school reported in Matlab Health and Socioeconomic

Survey dataset, 1996. http://www.icpsr.umich.edu/

slide-71
SLIDE 71

Vac f AR1v Nonvac 1-f AR1u Nonvac AR2u

Overall Direct Indirect Total

Intervention Population: 1 Control Population: 2

Vaccine Effectiveness

slide-72
SLIDE 72

Vac f AR1v Nonvac 1-f AR1u

Overall Direct Indirect Total VE

VE total

total = 1

= 1-

  • (AR1v / AR2u)

(AR1v / AR2u)

Intervention Population: 1 Control Population: 2

Vaccine Effectiveness

VE VEoverall

  • verall = 1

= 1-

  • (AR

(AR1ave

1ave/ AR

/ AR2u

2u)

) VE VEdirect

direct = 1

= 1-

  • (AR

(AR1v

1v / AR

/ AR1u

1u)

) VE VEindirect

indirect = 1

= 1-

  • (AR

(AR1u

1u / AR

/ AR2u

2u)

)

Nonvac AR2u

slide-73
SLIDE 73

Vaccine Effectiveness

VEdirect = 1- (AR1v / AR1u) VEindirect = 1- (AR1u / AR2u) VEtotal = 1- (AR1v / AR2u) VEoverall = 1- (AR1ave/ AR2u) where AR1ave = f AR1v + ( 1 – f) AR1u

Halloran, et al., Am J Epidemiol 146, 789-803 (1997)

slide-74
SLIDE 74

Vac f1 AR1v Nonvac 1-f1 AR1u

Overall Direct Indirect Total

Population: 1 Population: 2

Vaccine Effectiveness Gradient

Vac f2 AR2v Nonvac 1-f2 AR2u

Direct

slide-75
SLIDE 75

Model Calibration

  • Annual autumn/winter outbreaks in Matlab

10 20 30 40 50 60 70 80 90 100 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Month Average Number of Cases

slide-76
SLIDE 76

Vaccination Coverages, Average Incidence Rates and Direct Effectiveness (Calibration Runs) Mean Cases/1000 (95% CI) Vaccination Coverage (%) Placebo Vaccinated Mean Direct Effectiveness (%) (95% CI) Target Population Overall Population Observed Simulated Observed Simulated Observed Simulated 14 9 7.0 (6.5, 7.5) 7.8 (1.9, 14.8) 2.7 (1.9, 3.5) 2.8 (0.5, 6.1) 62 65 (52, 77) 31 20 5.9 (5.4, 6.4) 4.7 (0.9, 10.2) 2.5 (2.0, 3.0) 1.7 (0.3, 3.8) 58 65 (55, 76) 38 25 4.7 (4.2, 5.2) 3.8 (0.8, 8.6) 1.6 (1.2, 2.0) 1.3 (0.2, 3.4) 67 65 (54, 77) 46 30 4.7 (4.2, 5.2) 2.8 (0.5, 6.8) 2.3 (1.9, 2.7) 1.0 (0.1, 2.5) 52 66 (54, 79) 58 38 1.5 (1.2, 1.8) 1.8 (0.3, 4.8) 1.3 (1.0, 1.6) 0.6 (0.1, 1.8) 14 66 (51, 80)

χ² goodness-of-fit test for frequency data p = 0.84

slide-77
SLIDE 77

50 100 150 30 60 90 120 150 180 50 100 150 30 60 90 120 150 180 50 100 150 30 60 90 120 150 180

No Vaccination 11.2 cases/1000

50 100 150 30 60 90 120 150 180

14% Vaccination Unvacc. 7.6 cases/1000 Vacc. 2.7 cases/1000 58% Vaccination Unvacc. 1.8 cases/1000 Vacc. 0.6 cases/1000 38% Vaccination Unvacc. 3.7 cases/1000 Vacc. 1.3 cases/1000

Day Day

Cases/1000 Cases/1000

slide-78
SLIDE 78
slide-79
SLIDE 79

Average Indirect, Total and Overall Effectiveness of Vaccination, and Cases Prevented 10,000 Per Doses Mean Effectiveness (%) (95%CI) Vaccination Coverage (%) Indirect Total Overall Mean # Cases Prevented per 10,000 Doses 10 30 (-39, 83) 76 (47, 95) 34 (-30, 84) 50 30 70 (31, 93) 90 (76, 98) 76 (44, 95) 40 50 89 (72, 98) 97 (91, 99) 93 (82, 99) 30 70 97 (91, 99) 99 (97, 100) 98 (95, 100) 20 90 99 (98, 100) 100 (99, 100) 100 (99, 100) 20

slide-80
SLIDE 80

10 20 30 40 50 60 70 80 90 100

Vaccination Coverage (%) Effectiveness (%)

10 30 50 70 90 Total Overall Indirect

slide-81
SLIDE 81

Recommendations

  • For endemic cholera

– Should have at least 50% coverage – Vaccinate people every two years – If vaccine is limited, conduct environmental surveillance to target vaccination programs – Randomized community vaccine trial

  • For epidemic cholera

– Mobile stockpile of cholera vaccine – More work is needed to determine best vaccination strategy

  • Simulations
slide-82
SLIDE 82

Randomized Community Trial

  • Paired control and vaccinated

communities (at least 10 pairs).

  • Or at least a gradient in coverage
  • Could expand the WHO/IVI trial in

Mozambique to do this

  • Need study of environmental predictors of

cholera in Africa

slide-83
SLIDE 83

The End